Department of Surgery, College of Medicine, University of Cincinnati , Cincinnati, Ohio.
Am J Physiol Gastrointest Liver Physiol. 2019 Mar 1;316(3):G323-G331. doi: 10.1152/ajpgi.00154.2018. Epub 2018 Dec 13.
Liver recovery after hepatic ischemia-reperfusion (I/R) injury is characterized by clearance of dead tissue and its replacement with functional liver parenchyma. Previous reports have observed fibrosis after liver I/R. To determine whether liver fibrosis after I/R was a pathologic consequence of the injury response, we assessed the development of liver fibrosis after I/R and its impact on subsequent insult. A murine model of partial I/R was used to induce liver injury and study the reparative response. During liver remodeling after I/R, expression of the profibrotic genes increased in the ischemic liver. Histologically, α-smooth muscle actin (α-SMA)-positive hepatic stellate cells (HSCs)/myofibroblasts increased, and collagen deposition was enhanced along the injured site. Selective staining experiments showed that HSCs, not portal fibroblasts, were the major source of myofibroblasts. During liver repair after I/R, liver fibrosis was readily observed at the interface between necrotic tissue and regenerating liver in association with HSCs/myofibroblasts. The number of HSCs/myofibroblasts decreasing shortly after the full resolution of necrotic injury and restoration are normal liver architecture. However, liver fibrosis persisted for several more weeks before gradually resolving. Resolution of liver fibrosis was accompanied by upregulated expression of matrix metalloproteinase-13. After resolution of fibrosis, the administration of CCl4 did not result in exacerbated liver injury, suggesting that I/R injury does not predispose the liver to future fibrotic insults. The data suggest that liver fibrosis is a component of tissue repair after I/R, is caused by myofibroblasts derived from HSC, and does not increase susceptibility of the liver to subsequent hepatic injury. NEW & NOTEWORTHY This study is the first to assess pathology of liver fibrosis during the reparative process after ischemia-reperfusion (I/R) injury. Here we show that profibrotic gene expression increased in the liver after I/R, and collagen accumulation produced by hepatic stellate cells (HSCs)/myofibroblasts enhanced at the interface between necrotic tissue and regenerating liver. Liver fibrosis gradually resolved concomitant with decreasing activation of HSC and upregulating matrix metalloproteinase-13. After resolution of fibrosis, the liver was not more susceptible to subsequent hepatic injury.
肝脏在经历肝缺血再灌注(I/R)损伤后会进行自我修复,其特征是清除坏死组织并由功能性肝实质替代。先前的报告观察到 I/R 后会出现纤维化。为了确定 I/R 后肝脏纤维化是否是损伤反应的病理性后果,我们评估了 I/R 后肝脏纤维化的发展及其对后续损伤的影响。我们使用部分 I/R 的小鼠模型来诱导肝损伤并研究修复反应。在 I/R 后的肝重塑过程中,缺血性肝中纤维化相关基因的表达增加。组织学上,α-平滑肌肌动蛋白(α-SMA)阳性的肝星状细胞(HSCs)/肌成纤维细胞增加,胶原沉积在损伤部位增强。选择性染色实验表明,HSCs 而非门脉成纤维细胞是肌成纤维细胞的主要来源。在 I/R 后的肝修复过程中,在坏死组织与再生肝交界处很容易观察到肝纤维化,同时伴有 HSCs/肌成纤维细胞。在完全消除坏死损伤并恢复正常肝结构后不久,HSCs/肌成纤维细胞数量减少。然而,肝纤维化在数周后才逐渐消退。肝纤维化的消退伴随着基质金属蛋白酶-13 的表达上调。在纤维化消退后,给予 CCl4 不会导致肝损伤加剧,这表明 I/R 损伤不会使肝脏易患未来的纤维化损伤。数据表明,肝纤维化是 I/R 后组织修复的一个组成部分,是由 HSCs 衍生的肌成纤维细胞引起的,并且不会增加肝脏对后续肝损伤的易感性。